Regulatory Roundup: Top News Stories – Week Ending May 5, 2017

  This has been another exciting week with a flurry of regulatory activity in pharma and biotech. The FDA approved Radius Health’s drug TYMLOS to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies.  However, this included a “black box” warning that the treatment had increased the[…]